Biotech

All Articles

Fierce Biotech's Gabrielle Masson shows Strong 15 at NYSE

.Brutal Biotech Affiliate Editor Gabrielle Masson provided the 2024 training class of Intense 15 vic...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its own once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) progre...

Daiichi spends Merck $170M to form bronchi cancer cells T-cell engager pact

.Merck &amp Co. has actually swiftly gotten back some of the expenses of its own Harp on Therapeutic...

BioMarin stops preclinical gene treatment for heart disease

.After BioMarin performed a springtime well-maintained of its own pipeline in April, the company has...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks handle

.Huge Pharmas continue to be caught to the idea of molecular glue degraders. The current company to ...

Life science credit scores organization unveils along with $600M

.A brand new global lifestyle scientific research credit firm, nicknamed Symbiotic Resources, has ac...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing another huge bet from the Caforio age, ending a bargain for Agenus' T...

Nuvation halts BET inhibitor after considering stage 1 data

.After taking a look at phase 1 information, Nuvation Bio has decided to halt work with its one-time...

' Scientific intuition' led FDA experts to back Zevra's unusual health condition med

.Zevra Therapies' uncommon condition drug seems to be to become on the course to approval this fall ...

Pfizer takes $230M reached after axing stopped working DMD gene therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment failure has gone a $230 million gap...